 |
JHP Pharmaceuticals
To Produce Lyophilized Biologic
for International Late-Phase Clinical Trials
PARSIPPANY, NJ September 19, 2012 -- JHP
Pharmaceuticals, a provider of global contract
manufacturing services for sterile products has
entered into an agreement with an undisclosed
pharmaceutical company to produce supplies of a
lyophilized biologic for international, late-phase
clinical trials.
Stuart Hinchen president and CEO of JHP stated, “We know that customers
want to seamlessly progress from clinical batch
production to product launch and then
commercialization. JHP’s established infrastructure
and expertise transitioning products from clinical
to commercial supply are recognized by customers
looking for long- term reliability and continuity
when selecting a contract manufacturing
organization. Additionally, our cGMP compliance
record and experienced staff allows customers to
focus on their pressing business needs with
confidence.”
JHP has successfully supported launches of several products in US and
international markets and manufactures products for
sale in 86 countries. JHP’s Rochester, Michigan
manufacturing site’s 25-year history in contract
manufacturing is a result of a solid cGMP compliance
record, a quality-driven experienced staff and a
customer- centric approach.
About JHP Pharmaceuticals, LLC
JHP Pharmaceuticals, headquartered in New
Jersey, provides contract manufacturing of sterile products including biologics,
small molecule, controlled substances, vaccines, ophthalmics, otics and
antibiotics for large and small pharmaceutical and biotech organizations.
JHP’s sterile manufacturing facility, located in Rochester Michigan sits
on over 80 acres of land and includes a 171,000 sq. ft. production building and
warehouse. The production facility utilizes three high-speed filling lines, a
clinical filling line and four lyophilizers. The site also includes separate
facilities for chemistry, sterility testing, and analytical methods development.
JHP has the capability to manufacture small-scale clinical through
large-scale commercial products. JHP employs more than 370 staff in the USA in
its manufacturing, product development, regulatory, sales and marketing and
corporate areas. For more information, please visit
www.jhppharma.com.
|
|
|
|
Additional Press Releases |
|
|
|
04/17/13 |
|
JHP Pharmaceuticals To Produce Supplies of Biologic Drug Product For Late-Phase Clinical Trials |
 |
|
Webpage
|
PDF Format |
|
|
|
|
09/19/12 |
|
JHP Pharmaceuticals To Produce
Lyophilized Biologic for International
Late-Phase Clinical Trials
|
|
|
|
Webpage
|
PDF Format |
|
|
|
|
06/05/12 |
|
JHP Pharmaceuticals to Produce
Clinical and Commercial Supply of an
Innovative Injectable |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
02/29/12 |
|
JHP Pharmaceuticals Adds Second Product To Multi-Year Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
07/25/11 |
|
JHP Pharmaceuticals to Produce
Clinical Batches of Innovative Cardiac
Drug |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
07/06/11 |
|
JHP Pharmaceuticals Enters Agreement
To Produce Life-Saving Drug |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
07/05/11 |
|
JHP Pharmaceuticals Launches New
Multipack Presentations of Adrenalin®,
Coly-Mycin® M and Pitocin® |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
06/24/11 |
|
JHP Pharmaceuticals Announces Chief
Executive Officer Succession |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
03/28/11 |
|
JHP Pharmaceuticals Announces
Multi-Year Contract Manufacturing
Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
02/24/11 |
|
JHP Pharmaceuticals Enters Another Multi-Year
Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
01/27/11 |
|
JHP Pharmaceuticals & Putney Inc. Announce
Multi-Year Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
06/29/10 |
|
JHP Pharmaceuticals Announces Multi-Year
Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
05/10/10 |
|
JHP Pharmaceuticals Announces Successful
Completion of FDA and EMEA GMP Audits |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
09/28/09 |
|
JHP Announces FDA
Approval for Dantrium
IV, rapidly mixing in 20
seconds
|
|
|
|
Webpage
|
PDF Format |
|
|
|
|
08/20/08 |
|
JHP Pharmaceuticals &
SpePharm complete
purchaseof Dantrium®
(dantrolene sodium)
|
|
|
|
Webpage
|
PDF Format |
|
|
|
|
07/16/07 |
|
King Pharmaceuticals Completes Sale
Of Rochester, Michigan Manufacturing
Facility To JHP Pharmaceuticals |
|
|
|
Webpage
|
PDF Format |
|
|
|
Return To Press Releases
»
|
 |
To contact JHP Pharmaceuticals regarding
product information or general
questions, please
Contact Us
»
Request additional information about JHP
Pharmaceuticals or product information.
Information Request
»
|
|
